Try our Advanced Search for more refined results

November 11, 2014

LI v. AETERNA ZENTARIS, INC. et al

Track this case

Case Number:

3:14-cv-07081

Court:

New Jersey

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Peter G. Sheridan

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 24, 2020

    Aeterna, Shareholders Reach $6.5M Hormone Drug Deal

    Investors in biopharmaceutical company Aeterna Zentaris Inc. asked a New Jersey federal judge Thursday to approve a $6.5 million deal to end class action allegations that the company lied about the success of a potential new hormone deficiency drug, causing its stock price to plummet.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login